Medical Records for Sickle Cell Care in China: Diagnosis, Blood Compatibility, Crises, and Treatment History

Preparing records for sickle cell care is less about producing a large stack of paper than enabling a new team to understand the patient's usual condition, serious past events, and current treatment. A blood count describes one moment. Diagnostic evidence, transfusion history, and changes in symptoms together provide the context needed for decisions.

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

A cover summary can include name and date of birth, diagnosis and its supporting evidence, the main treating service, current medicines, and the reason for consultation. Prioritize the problem driving the visit, such as repeated emergency admissions, review of regular transfusion, concern about cerebrovascular disease, or transplant assessment. Include current symptoms, the most recent admission and transfusion dates, and a contact for the existing team.
The medicine list should identify generic name, formulation, dose per administration, frequency, and start or stop dates. For hydroxyurea, include the course of dose adjustments and interruptions due to counts, adverse effects, supply problems, or other reasons. Discontinuation does not always mean treatment failure. Clinicians need to distinguish inadequate benefit from intolerance, monitoring difficulties, and access barriers.[S36][S55]
Folders for diagnosis, treatment, transfusion, admissions, organ testing, and the current plan can make a large record easier to navigate. Use dates and meaningful descriptions in filenames. Check each scan for missing pages and readability, particularly when messaging applications reduce image quality. Link translations to the original documents and mark uncertain terminology rather than treating a machine-generated guess as a confirmed conclusion.

Quick answer

Full guide

Whether seeking a second opinion, attending a hospital in China, or considering transplantation, keep the original documents and add a concise index. Do not remove abnormal results or old antibody reports to make the file look simpler. When information is missing, mark the gap and ask the original institution for it rather than reconstructing numbers from memory.

Put the current question on the first page

A cover summary can include name and date of birth, diagnosis and its supporting evidence, the main treating service, current medicines, and the reason for consultation. Prioritize the problem driving the visit, such as repeated emergency admissions, review of regular transfusion, concern about cerebrovascular disease, or transplant assessment. Include current symptoms, the most recent admission and transfusion dates, and a contact for the existing team.

Each important statement should point to a supporting attachment. For a previous delayed hemolytic reaction, identify the discharge report and laboratory dates. For an apparently inadequate hydroxyurea response, list treatment duration, adjustments, and events during treatment. The summary should help clinicians locate the evidence rather than replace it with a family interpretation. Ask the original team to check doses, diagnoses, and serious adverse-event details where possible.[S36][S4]

Keep the full diagnostic reports

Bring complete hemoglobin analysis, including the method, fractions, laboratory interpretation, and specimen date. For HBB or related molecular testing, retain variant names, test scope, and the laboratory conclusion rather than a cropped statement saying positive. HbSS, HbSC, and sickle beta-thalassemia can involve different clinical considerations, and the new team needs to know how the genotype was established.[S1][S29][S30]

Note the patient's age at testing, recent transfusions, hydroxyurea use, and any previous transplant or gene therapy. Donor red cells, age-related hemoglobin changes, and treatment can influence interpretation. Newborn and family-screening records may also be useful. A different proportion on a later report does not independently prove that the inherited diagnosis has changed.[S30][S31]

Show the baseline through dated results

Arrange representative blood counts, reticulocytes, bilirubin, and other relevant hemolysis results by date. Identify whether the sample was taken during ordinary health, a crisis, infection, or after transfusion. The patient's usual hemoglobin and reticulocyte pattern helps clinicians recognize a meaningful change. Bring recent results and important historical points, rather than selecting only the most reassuring report.[S36][S37]

Retain units, reference ranges, and the laboratory name. A translated test name can sit alongside the original, but numbers should not be silently converted or copied without their units. If conversion is needed, ask medical staff to check it. Scans should show the whole page, date, and identifying details rather than only a circled result.

Build a transfusion record beyond ABO and RhD

Blood group alone is insufficient for transfusion planning in sickle cell disease. Provide extended red-cell phenotype or genotype testing when available, every previously identified antibody, compatibility difficulties, and transfusion reactions with their management. An antibody that is absent from a later screen should still remain in the history. This matters particularly when care moves between institutions or countries.[S35]

For each important transfusion episode, record the indication, simple transfusion or exchange, required blood characteristics, and measured pre- and post-treatment hemoglobin and HbS where available. Definitions of a unit or bag can differ, so retain the original transfusion record instead of estimating the volume from a number of bags. Identify outstanding documents and tell the receiving team about gaps early.[S35][S58]

Highlight serious reactions separately

If jaundice, dark urine, worsening pain, substantial anemia, or readmission occurred after transfusion, include the timeline, laboratory results, and the treating team's assessment. Delayed hemolysis may appear after discharge and can resemble another crisis. The interval between transfusion and symptoms can help clinicians reconstruct what happened. Do not hide this history within a general medicine-allergy list.[S35]

Retain any instructions concerning special matching, particular blood products, preventive treatment, or caution with further transfusion. A prominent summary can alert the new team without converting a previous recommendation into a permanent prohibition against transfusion under all circumstances. Future decisions depend on the clinical urgency as well as the reaction history.

Describe crises by type and effect

Create a dated list of emergency visits and admissions, distinguishing pain, acute chest syndrome, infection, stroke, splenic events, and other problems. Combining everything into a single count of attacks can obscure important differences. Attach key discharge summaries, chest imaging, microbiology results, oxygen requirements, and intensive-care details to show what each event involved.[S4][S57]

Pain managed at home is also relevant. Record its location, duration, treatment, and effect on sleep, school, or work. The patient's own description is useful; there is no need to invent a precise score for an episode that cannot be recalled accurately. The new team needs to distinguish acute crises from persistent pain and learn which treatments helped or caused burdens such as sedation or constipation.[S4][S67]

Explain why medicines changed

The medicine list should identify generic name, formulation, dose per administration, frequency, and start or stop dates. For hydroxyurea, include the course of dose adjustments and interruptions due to counts, adverse effects, supply problems, or other reasons. Discontinuation does not always mean treatment failure. Clinicians need to distinguish inadequate benefit from intolerance, monitoring difficulties, and access barriers.[S36][S55]

Include chelation, preventive antibiotics, analgesics, anticoagulants, and nonprescription products. For deferiprone or deferasirox, provide the relevant blood-cell, liver, and kidney monitoring and adverse-event history. Record actual analgesic use rather than copying only the maximum permitted dose. Sedatives, alcohol use, and other medicines can affect safety and should be discussed accurately.[S82][S83][S85]

If prescriptions from different hospitals conflict, keep both and mark what the patient is currently taking. Do not resolve the conflict by quietly deleting one instruction. A clinician or pharmacist can reconcile the list and clarify which plan remains active. Photographs of current packaging can help identify formulations when brand names differ between countries.

Make organ assessments comparable

For cerebrovascular care, bring transcranial Doppler reports, brain MRI and vascular imaging, and neurology conclusions. Note transient neurological symptoms, established stroke, learning concerns, or cognitive changes. Different ultrasound techniques should not be presented as interchangeable tests. When imaging data are available, use the receiving center's requested format rather than photographs of a screen.[S6]

Kidney records should include trends in relevant blood tests, urine protein or albumin, blood pressure, and treatment. Include specialist reports for cardiopulmonary symptoms, eye disease, osteonecrosis, or leg ulcers. Liver-iron MRI reports should retain the method and date so that a new team can assess change over time. A ferritin result alone cannot replace the full iron-assessment history.[S7][S35][S40]

Keep a short list of unresolved findings and planned repeat assessments. For example, a report that prompted a referral should be accompanied by the outcome of that referral if it occurred. If an investigation was recommended but never completed, say so explicitly. This prevents the receiving team from assuming that an abnormality was already addressed elsewhere.

Include procedures, anesthesia, and devices

Provide records of splenectomy, gallbladder surgery, joint procedures, and other major operations. Relevant details include anesthesia, perioperative transfusion, infection, and chest complications. These can inform planning for future procedures. An earlier uncomplicated operation is useful history but does not guarantee that every subsequent procedure has the same risk.[S48]

If a port or other vascular device remains in place, include its type, insertion date and side, maintenance, and infection history. Retain the implant card or procedure report when the family is uncertain of the device name. Existing respiratory or rehabilitation plans can also help a receiving team understand what support is already needed.

Transplant and gene-therapy records require precise identification

After allogeneic transplantation, collect donor details, transplant date, conditioning, chimerism trends, graft-versus-host disease, infections, and immunosuppressive treatment. Later anemia or fever may reflect several possibilities and should not automatically be described as recurrence of the original disease. The new team needs the treatment history to distinguish them.[S8]

For gene therapy, retain the exact product, batch information, infusion date, conditioning, blood-cell recovery, serious adverse events, and surveillance plan. CASGEVY and LYFGENIA have different mechanisms and monitoring requirements; a note saying gene treatment was performed is inadequate. In particular, the new team needs to know how product-specific long-term surveillance, including LYFGENIA's malignancy monitoring, is being maintained.[S13][S45]

Identify which clinician or center remains responsible for long-term reporting and how results should be shared. Moving routine care does not necessarily transfer every monitoring obligation automatically. A written handover allows both services to see what has been completed, what is due, and how an unexpected finding will be managed.

Include prevention, reproduction, and daily function

Bring vaccination records, splenectomy or splenic-function information, serious infection history, and preventive antibiotic plans. For children, growth, school support, and cognitive assessments can show how the disease affects development. For adults, stamina, sleep, work difficulties, and psychological support needs are clinically relevant even when they do not appear on a laboratory report.[S9][S4]

Pregnancy, plans to conceive, and previous fertility preservation should be accompanied by maternity, genetic counseling, and treatment records, including recent medication changes. A partner's screening report contains that person's information and should be shared with permission and as needed. Sensitive reproductive questions can be discussed directly with the clinician without distributing all details to every scheduling contact.[S18][S29]

Organize access while keeping your own copy

Folders for diagnosis, treatment, transfusion, admissions, organ testing, and the current plan can make a large record easier to navigate. Use dates and meaningful descriptions in filenames. Check each scan for missing pages and readability, particularly when messaging applications reduce image quality. Link translations to the original documents and mark uncertain terminology rather than treating a machine-generated guess as a confirmed conclusion.

Confirm the hospital's submission channel, accepted formats, and any need for paper originals. Send relevant records through an established route and retain an accessible personal copy of the summary, medication list, and antibody information, with a full backup. Explain differences in spelling between passports and previous hospital records so important results can be matched to the correct patient.

After submission, ask which specific items are still missing rather than repeatedly resending every attachment. Update the file for recent symptoms and prescription changes before attendance. Good records reduce uncertainty but do not replace clinical assessment. New fever, chest symptoms, or neurological changes require prompt care; completing a document folder should never delay help.[S24]